↓ Skip to main content

Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1

Overview of attention for article published in New England Journal of Medicine, April 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Citations

dimensions_citation
212 Dimensions

Readers on

mendeley
334 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1
Published in
New England Journal of Medicine, April 2019
DOI 10.1056/nejmoa1815408
Pubmed ID
Authors

Ewelina Mamcarz, Sheng Zhou, Timothy Lockey, Hossam Abdelsamed, Shane J Cross, Guolian Kang, Zhijun Ma, Jose Condori, Jola Dowdy, Brandon Triplett, Chen Li, Gabriela Maron, Juan C Aldave Becerra, Joseph A Church, Elif Dokmeci, James T Love, Ana C da Matta Ain, Hedi van der Watt, Xing Tang, William Janssen, Byoung Y Ryu, Suk See De Ravin, Mitchell J Weiss, Benjamin Youngblood, Janel R Long-Boyle, Stephen Gottschalk, Michael M Meagher, Harry L Malech, Jennifer M Puck, Morton J Cowan, Brian P Sorrentino

X Demographics

X Demographics

The data shown below were collected from the profiles of 842 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 334 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 334 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 51 15%
Researcher 46 14%
Student > Ph. D. Student 36 11%
Other 25 7%
Student > Master 22 7%
Other 56 17%
Unknown 98 29%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 83 25%
Medicine and Dentistry 49 15%
Agricultural and Biological Sciences 23 7%
Immunology and Microbiology 19 6%
Pharmacology, Toxicology and Pharmaceutical Science 8 2%
Other 42 13%
Unknown 110 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1607. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 September 2023.
All research outputs
#6,988
of 25,721,020 outputs
Outputs from New England Journal of Medicine
#374
of 32,655 outputs
Outputs of similar age
#117
of 364,932 outputs
Outputs of similar age from New England Journal of Medicine
#1
of 273 outputs
Altmetric has tracked 25,721,020 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,655 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,932 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 273 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.